Keywords: AR; Androgen Receptor; BPH; Benign Prostatic Hyperplasia; LUTS; Lower Urinary Tract Symptoms; PVR; Post-Void Residual; AUR; Acute Urinary Retention; AUASS; American Urological Association Symptom Score; PSA; Prostate Specific Antigen; 5ARI; 5 Alpha Reduct
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: APTMS; 3-aminopropyltriethoxysilane; 8-OHdG; 8-hydroxydeoxyguanosine; BRE; Bio-recognition element; BRCA-1; Breast cancer 1 gene; CNTs; Carbon nanotubes; CLL; Chronic lymphocytic leukemia; EIS; Electrochemical impedance spectroscopy; ELISA; Enzyme linked
Keywords: AC; Alternating Current; ADS; Automatic Depressurization System; AWI; Alternative Water Injection; BAF; Bottom of Active Fuel; BWR; Boiling Water Reactor; CCF; Common Cause Failure; CD; Core Damage; CDF; Core Damage Frequency; CST; Condensate Storage Tank
Keywords: CKD; chronic kidney disease; ESRD; end-stage renal disease; PSA; polysaccharides; CVD; cardiovascular disease; IS; indoxyl sulfate; TMAO; trimethylamine-N-oxide; SCFA; short chain fatty acid; PCS; p-cresol sulfate; Tregs; regulatory T cells; IRI; ischemia
Keywords: Extended BEPU; PSA; Option 4; Realistic approach; Probabilistic; Deterministic; Uncertainty; Safety analysis; Best Estimate Plus Uncertainty methodology; Design basis conditions; Design extension conditions;
Keywords: prostatic neoplasms; neoplasm metastasis; bone neoplasms; diagnostic imaging; quality improvement; AUA; American Urological Association; BS; bone scan; CT; computerized tomography of abdomen and/or pelvis; EMR; electronic medical record; GS; Gleason scor
Keywords: prostatic neoplasms; watchful waiting; gene expression; AS; active surveillance; BCR; biochemical recurrence; CaP; prostate cancer; CCP; cell cycle progression; GPS; genomic prostate score; mpMRI; multiparametric magnetic resonance imaging; MR; magnetic r
Keywords: prostatic neoplasms; immunotherapy; ADT; androgen deprivation therapy; APC; antigen presenting cell; CRPC; castration resistant prostate cancer; GM-CSF; granulocyte-macrophage colony-stimulating factor; mCRPC; metastatic castration resistant prostate canc
Keywords: AC; Alternate Current; AFW; Auxiliary Feed Water; BDBA; Beyond Design Basis Accident; BE; Best Estimate; DBA; Design Basis Accident; DET; Dynamic Event Tree; DOE; Department Of Energy; DPSM; Dynamic Probabilistic Safety Margin; ET; Event Tree; FT; Fault T
Keywords: ALP; alkaline phosphatase; AS; ankylosing spondylitis; BSA; bovine serum albumin; CT; connective tissue; H/E; hematoxylin/eosin; HS; horse serum; MP; dry milk; OA; osteoarthritis; OPG; osteoprotegerin; PsA; psoriatic arthritis; RA; rheumatoid arthritis; S
Keywords: Biogas upgrading; Cost; Utilisation; Bio-CNG; Storage; AS; amine scrubbing; AMDEA; activated methyl diethanolamine; Bio-CNG; bio-compressed natural gas; CA; cellulose acetate; CSP; chemical scrubbing process; CNG; compressed natural gas; CHP; combined hea
Keywords: PSA; Diabetes mellitus; HbA1c;
Keywords: ASU; air separation unit; ATR; auto thermal reforming; BR; bi-reforming; CR; combined reforming; DMR; dry methane reforming; GWP; Global Warming Potential; HI; heat integration; LCIA; Life Cycle Impact Assessment; POX; partial oxidation; PSA; pressure swi
Keywords: BoNT; botulinum neurotoxin; CT; cholera toxin; PAMPs; pathogen-associated molecular patterns; ENS; enteric nervous system; PSA; polysaccharide A; SCFAs; short-chain fatty acids; CNS; central nervous system; GABA; γ-aminobutyric acid; TeNT; tetanus neurot
Keywords: prostatic neoplasms; prostate-specific antigen; mortality; mass screening; bias; CA; control arm; ERSPC; European Randomized Study of Screening for Prostate Cancer; PCa; prostate cancer; PLCO; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
Keywords: prostatic neoplasms; prostate-specific antigen; watchful waiting; biopsy; quality improvement; AS; active surveillance; MRI; magnetic resonance imaging; PSA; prostate specific antigen;
Keywords: prostatic neoplasms; social support; marital status; quality of life; HRQOL; health related quality of life; IMPACT; Improving Access, Counseling, and Treatment for Californians with Prostate Cancer; PCI-SF; UCLA Prostate Cancer Index Short Form; PSA; pro
Keywords: prostatic neoplasms; prostate-specific antigen; early detection of cancer; CoC; Commission on Cancer; mpMRI; multiparametric magnetic resonance imaging; NAMCS; National Ambulatory Medical Care Survey; NCDB; National Cancer Database; NHIS; National Health
Keywords: PGA; physician's global assessment; PGE; parental global evaluation; ESR; erythrocyte sedimentation rate; JADAS; Juvenile Arthritis Disease Activity Score; cJADAS; clinical JADAS; PICO; Patient Intervention Comparison Outcome; JRA; juvenile rheumatoid a
Keywords: prostatic neoplasms; stress; psychological; watchful waiting; clinical decision-making; AJCC; American Joint Committee on Cancer; AS; active surveillance; CVD; cardiovascular disease; PCa; prostate cancer; PSA; prostate specific antigen; RRR; relative ri
Keywords: prostatic neoplasms; neoplasm grading; neoplasm staging; watchful waiting; African Continental Ancestry Group; AA; African-American; CCI; Charlson-Deyo comorbidity index; NCDB; National Cancer Database; PCa; prostate cancer; PSA; prostate specific antige
Keywords: prostatic neoplasms; prostatectomy; carcinoma; ductal; prognosis; neoplasm recurrence; local; AAP; acinar adenocarcinoma of prostate; BCR; biochemical recurrence; DAP; ductal adenocarcinoma of prostate; DC; ductal component; EPE; extraprostatic extension;
Keywords: prostatic neoplasms; biopsy; diagnosis; mortality; risk; ACM; all-cause mortality; DRE; digital rectal examination; PCa; prostate cancer; PCSM; prostate cancer specific mortality; PSA; prostate specific antigen; TRUS; transrectal ultrasound;
Keywords: prostatic neoplasms; neoplasm staging; practice guidelines as topic; guideline adherence; ADT; androgen deprivation therapy; APC; advanced prostate cancer; CRPC; castration resistant prostate cancer; EMR; electronic medical record; IUOGP; integrated urolo
Ultrasound-assisted liquid-liquid extraction followed by ultrahigh pressure liquid chromatography for the quantification of major carotenoids in tomato
Keywords: ACN; acetonitrile; BHT; butylhydroxytoluene; DCM; dichloromethane; EtOH; ethanol; FMG; full mature green; FW; fresh weight; Hex; hexane; HL; high level; L; low level; IG; immature green; LLE; Liquid-liquid extraction; LLUSAE,UHPLC-PDA; ultrasound-assisted
Keywords: prostatic neoplasms; magnetic resonance imaging; image-guided biopsy; diagnostic imaging; risk; CS; clinically significant; DRE; digital rectal examination; FBx; MRI/TRUS fusion-guided biopsy; mpMRI; multiparametric MRI; MRI; magnetic resonance imaging; P
Keywords: prostatic neoplasms; organ specificity; prostate-specific antigen; nomograms; neoplasm grading; BCR; biochemical recurrence; CZ; central zone; EPS; extraprostatic spread; IDCP; intraductal carcinoma; ISUP; International Society of Urological Pathology; PS
Keywords: Rodents; mouse model; mast cells/basophils; monocytes/macrophages; neutrophils; antibodies; Fc receptors; allergy; inflammation; anaphylaxis; ASA; Active systemic anaphylaxis; BMCMC; Bone marrow-derived cultured mast cell; Cpa3; Carboxypeptidase A3; DT;
Keywords: prostatic neoplasms; watchful waiting; prostatectomy; prostate-specific antigen; neoplasm grading; AS; active surveillance; BCR; biochemical recurrence; bRFS; BCR-free survival; GR; grade reclassification; GS; Gleason score; IRP; immediate radical prostat
Keywords: prostatic neoplasms; prostatic intraepithelial neoplasia; biopsy; quality improvement; diagnosis; ASAP; atypical small acinar proliferation; BCBSM; Blue Cross Blue Shield of Michigan; DRE; digital rectal examination; HGPIN; high grade prostatic intraepith
Keywords: prostate; prostatectomy; margins of excision; surgeons; quality improvement; ACS-NSQIP®; American College of Surgeons National Surgical Quality Improvement Program®; CQPR; comparative quality performance review; NCCN®; National Comprehensive Cancer Ne
Keywords: prostatic neoplasms; sentinel surveillance; epidemiology; risk factors; mortality; ACM; all cause mortality; AS; active surveillance; mpMRI; multiparametric magnetic resonance imaging; MSKCC; Memorial Sloan Kettering Cancer Center; NCCN®; National Compr
Keywords: BPAGDA; bisphenol A glycerolate diacrylate; CDG; conjugate diene group; DA reaction; Diels-Alder reaction; DG; dienophile group; MPMI; 4,4'-methylene-bis(N-phenylmaleimide); PET; polyethylene terephthalate; PPGDA; poly(propylene glycol) diacrylate; PSA;
Keywords: prostate; prostate-specific antigen; 5-alpha reductase inhibitors; alopecia; dihydrotestosterone; 5aR; 5α-reductase; 5aRI; 5aR inhibitor; BPH; benign prostatic hyperplasia; PSA; prostate specific antigen;
Keywords: preventive health services; early detection of cancer; prostate-specific antigen; surveys and questionnaires; HINTS; Health Information National Trends Survey; PSA; prostate specific antigen; USPSTF; U.S. Preventive Services Task Force;
Keywords: prostatic hyperplasia; prostatectomy; robotics; lasers; solid-state; outcome assessment (health care); BPH; benign prostatic hyperplasia; CV; catheterization; Hb; hemoglobin; HoLEP; holmium laser enucleation of prostate; LOS; length of stay; LUTS; lower u
Keywords: prostatic hyperplasia; laser therapy; learning curve; mentors; urinary incontinence; BPH; benign prostatic hyperplasia; CD; case difficulty; GMP; grossly multinodular prostate; HoLEP; holmium laser enucleation of prostate; LCC; learning curve characteriza
Keywords: prostatic neoplasms; prostatectomy; neoplasm metastasis; castration; mortality; CSS; cancer specific survival; OS; overall survival; PCa; prostate cancer; pN+; pathological node positive; PSA; prostate specific antigen; RRP; radical retropubic prostatecto
Keywords: prostatic neoplasms; androgen antagonists; antineoplastic agents; hormonal; drug related side effects and adverse reactions; risk; ADT; androgen deprivation therapy; AMI; acute myocardial infarction; CADT; continuous ADT; GnRH; gonadotropin-releasing horm
Keywords: prostatic neoplasms; prostate-specific antigen; watchful waiting; African continental ancestry group; Caribbean region; AS; active surveillance; BCR; biochemical recurrence; CAPRA-S; Cancer of the Prostate Risk Assessment Postsurgical; DRE; digital rectal
Keywords: prostatic neoplasms; prostatectomy; robotic surgical procedures; salvage therapy; surveys and questionnaires; AS; active surveillance; BCR; biochemical recurrence; EBL; estimated blood loss; FT; focal therapy; ICSmaleIS; International Continence Society m
Keywords: prostatic neoplasms; prostatectomy; lymph node excision; lymphatic metastasis; mortality; ADT; androgen deprivation therapy; CCI; Charlson comorbidity index; ECOG; Eastern Cooperative Oncology Group; LN; lymph node; NCDB; National Cancer Database; OS; ove
Keywords: prostatic neoplasms; prostate-specific antigen; androgen antagonists; delayed-action preparations; calcium sulfate; 2D; 2-dimensional; 2-HOF; 2-hydroxyflutamide; ADC; apparent diffusion coefficient; Cho; choline; Cit; citrate; Cr; creatine; DWI; diffusion
Keywords: permeability; ophthalmic drug delivery; QSPR; absorption; principal component analysis; partial least square; HBD; hydrogen bond donor; logD7.4; the logarithm of the octanol-water partition coefficient at pH 7.4; MW; molecular weight; Papp,CJ; apparent co
Keywords: prostatic neoplasms; obesity; watchful waiting; prostatectomy; risk factors; AS; active surveillance; BMI; body mass index; GS; Gleason score; JHH; Johns Hopkins Hospital; MRI; magnetic resonance imaging; MSKCC; Memorial Sloan Kettering Cancer Center; PCa
Keywords: biopsy; China; early detection of cancer; prostatic neoplasms; prostate-specific antigen; DRE; digital rectal examination; Durham VA; Durham Veteran Affairs Hospital; ERSPC; European Randomized Study of Screening for Prostate Cancer; HGPCa; high grade pro
Keywords: prostatic neoplasms; neoplasm recurrence; local; androgen antagonists; salvage therapy; mortality; ADT; androgen deprivation therapy; AUA; American Urological Association; PSA; prostate specific antigen; SADT; salvage androgen deprivation therapy; TOAD;
Keywords: decision support systems; clinical; prostatic neoplasms; prostate-specific antigen; AA; African American; AUA; American Urological Association; DA; decision aid; FG; focus group; PSA; prostate specific antigen; SDM; shared decision making; USPSTF; U.S. Pr
Keywords: PCP; physicochemical properties; Ro5; Lipinski rule of five; PCA; principal component analysis; AlogP; partition coefficient; GABA; gamma-aminobutyric acid; PSA; polar surface area; MR; molecular refractivity; QED; quantitative estimate of drug-likeness;
Keywords: prostatic neoplasms; photochemotherapy; WST11 compound; therapeutic occlusion; treatment outcome; AS; active surveillance; CSC; clinically significant cancer; FT; focal therapy; HIFU; high intensity focused ultrasound; IIEF; International Index of Erectil